Aidoc Review 2026

Aidoc's aiOS platform analyzes medical data, prioritizes suspected findings, and connects care teams across hospital workflows.

Aidoc is an enterprise clinical AI vendor focused on inserting machine-generated findings into real hospital workflows. Its aiOS platform is designed as a common operating layer for AI applications, rather than a single radiology model. The vendor’s September 2026 homepage says Aidoc is used by more than 1,600 medical centers worldwide and that its solutions can touch 75% of patients in a health system. Its radiology portfolio automatically analyzes medical imaging, prioritizes suspected urgent findings, activates care teams, and supports follow-up. The site also covers cardiology, neurovascular, and vascular workflows, including coronary artery disease, stroke, brain aneurysm, pulmonary embolism, deep-vein thrombosis, aortic disease, and IVC-filter follow-up.

The practical value is orchestration. aiOS connects applications with existing imaging and clinical systems; Care Coordination routes notifications and context to the appropriate users; Patient Management helps identify, capture, and follow patients over time; and Systems Integrations offers custom configuration with what Aidoc describes as minimal IT lift. The platform can also host vetted third-party algorithms and OEM partners. That architecture distinguishes Aidoc from buying isolated algorithms that each require separate integration, governance, monitoring, and user training. Aidoc cites workflow outcomes including 31% faster time-to-notification for pulmonary embolism and a 34% reduction in door-to-puncture time for stroke. Those figures are useful signals, but a hospital should inspect the linked study design, population, baseline, and local reproducibility before including them in an ROI model.